Innovative AI Platform Ari Supports Gallbladder Cancer Patients and Families#Springfield#Ari#Citizen_Health#Gallbladder_Cancer_Foundation
Innovative AI Platform Ari Supports Gallbladder Cancer Patients and Families
The Gallbladder Cancer Foundation and Citizen Health have intensified their collaboration to support gallbladder cancer patients with Ari, an AI platform designed to assist in their care.
third-news.com
July 24, 2026 at 12:20 PM
Innovative AI Platform Ari Supports Gallbladder Cancer Patients and Families#Springfield#Ari#Citizen_Health#Gallbladder_Cancer_Foundation
Global Genes and Citizen Health Join Forces to Launch Innovative RARE-X Platform for Rare Diseases#United_States#San_Francisco#Global_Genes#RARE-X#Citizen_Health
Global Genes and Citizen Health Join Forces to Launch Innovative RARE-X Platform for Rare Diseases
Global Genes partners with Citizen Health to enhance its RARE-X platform, focusing on rare disease data collection and patient-centric care solutions.
third-news.com
September 8, 2026 at 1:06 PM
Global Genes and Citizen Health Join Forces to Launch Innovative RARE-X Platform for Rare Diseases#United_States#San_Francisco#Global_Genes#RARE-X#Citizen_Health
Innovative AI Advocate Platform Launched for Gallbladder Cancer Patients#USA#Springfield#Citizen_Health#AI_Advocate#Gallbladder_Cancer
Innovative AI Advocate Platform Launched for Gallbladder Cancer Patients
The Gallbladder Cancer Foundation has partnered with Citizen Health to introduce an AI-driven platform that supports gallbladder cancer patients with managing their medical histories and options.
third-news.com
February 25, 2026 at 4:32 PM
Innovative AI Advocate Platform Launched for Gallbladder Cancer Patients#USA#Springfield#Citizen_Health#AI_Advocate#Gallbladder_Cancer
Citizen Health Secures $30 Million to Innovate Patient Advocacy with AI Technology#United_States#San_Francisco#Rare_Diseases#Citizen_Health#AI_Advocate
Citizen Health Secures $30 Million to Innovate Patient Advocacy with AI Technology
Citizen Health announces a significant $30 million funding for developing AI advocates, enhancing healthcare experiences for patients with rare diseases.
third-news.com
August 14, 2025 at 3:17 PM
Citizen Health Secures $30 Million to Innovate Patient Advocacy with AI Technology#United_States#San_Francisco#Rare_Diseases#Citizen_Health#AI_Advocate
Citizen Health and Rocket Pharma Unite to Transform Patient Outcomes in Rare Cardiomyopathy Treatment#USA#San_Francisco#Rocket_Pharma#Citizen_Health#PKP2_Cardiomyopathy
Citizen Health and Rocket Pharma Unite to Transform Patient Outcomes in Rare Cardiomyopathy Treatment
Citizen Health's partnership with Rocket Pharma focuses on enhancing drug development and patient experiences in treating PKP2 Cardiomyopathy, a rare heart condition.
third-news.com
May 7, 2025 at 12:26 PM
Citizen Health and Rocket Pharma Unite to Transform Patient Outcomes in Rare Cardiomyopathy Treatment#USA#San_Francisco#Rocket_Pharma#Citizen_Health#PKP2_Cardiomyopathy